NAFDAC Cautions Against Counterfeit Phesgo 600mg Injection In Nigerian Market

NAFDAC Cautions Against Counterfeit Phesgo 600mg Injection In Nigerian Market

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a warning about a suspected counterfeit batch of Phesgo® 600mg/600mg with the batch number C3809C51………. CONTINUE READING

Roche, the Marketing Authorization Holder, received a complaint from a pharmacist regarding this counterfeit batch. Although no physical sample was returned to Roche, photographs showed significant deviations from authentic Phesgo® products. Issues included mismatched batch numbers, incorrect tamper-evidence labels, and inconsistencies in vial dimensions and labeling.

The counterfeit product, which is solid instead of the genuine liquid, bears similarities to other counterfeit cases reported in Libya, including similar batch numbers and Bollino labels.

NAFDAC has directed its regional coordinators to enhance surveillance and remove counterfeit products from circulation. Importers, distributors, and healthcare providers are advised to verify the authenticity of products and report any suspicions to NAFDAC.

Healthcare professionals and consumers are encouraged me to report suspected counterfeits or adverse effects to NAFDAC via phone, email, or online platforms. This alert will also be communicated to the WHO Global Surveillance and Monitoring System.